Barely Significant
← all excerpts

Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC.

Signal Transduct Target Ther · 2022 · PMC8904860 · PMID 35260570

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
For example, in 3 cases involving pre-treatment, on-treatment (recurrence), and post-treatment (acquired resistance) samples, we found that 317 genes showed a trend of increased expression in at least two samples and that 389 genes showed decreased expression in at least two samples (Fig. 6a and Supplementary Fig. 9a–d ).

also in 53,322 other papers

an increasing trendno p-value reported
For the WES data, analyses of single-nucleotide variants (SNVs) and of copy number variants (CNVs) indicated that increased drug resistance is often accompanied by an increasing trend for mutations in candidate cancer genes in the Network of Cancer Genes 24 , such as ERBB2 , IL24 , E2F1 , CDK1, MMP10, MMP13, etc.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.